NEOGENOMICS INC 8-K

What Happened

• On January 12, 2026, NeoGenomics, Inc. issued a press release disclosing select preliminary unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025, including preliminary revenue figures (amounts are based on management estimates and may change). The company’s independent auditors have not reviewed or audited these preliminary results.
• The company also announced a planned finance leadership transition: CFO Jeffrey S. Sherman notified the board on January 9, 2026 of his intention to retire. Sherman will transition to Executive Vice President, Finance effective March 2, 2026, serve in that role through his retirement on April 14, 2026, and is expected to act as a special advisor through April 2028.
• Abhishek Jain (50) was appointed Executive Vice President, Finance effective January 12, 2026, and is expected to assume the Chief Financial Officer role on March 2, 2026. Jain’s background includes prior roles as Chief Financial Officer and Corporate Controller at CareDx and nearly 20 years in finance at Agilent Technologies.

Key Details

• Press release date: January 12, 2026 (Exhibit 99.1 furnished with the Form 8‑K).
• Preliminary financials: select unaudited revenue results for Q4 and FY2025 were announced; management estimates only and subject to change; independent auditors have not audited or reviewed them.
• Executive timing: Sherman notified board Jan 9, 2026; transitions to EVP, Finance on Mar 2, 2026; retirement effective Apr 14, 2026; will serve as special advisor through Apr 2028.
• Jain’s compensation: $520,000 annual base salary, 60% target annual incentive, and an initial equity award with a grant value of $2,750,000 (50% RSUs vesting ratably over 3 years; 50% premium-priced stock options vesting ratably over 3 years).

Why It Matters

• Earnings/revenue: The preliminary, unaudited revenue disclosure gives an early indicator of Q4/FY2025 performance but is expressly subject to change and not audited — investors should wait for the final audited results for confirmation.
• Leadership continuity: The planned overlap between Sherman and Jain, plus Sherman’s extended advisory role through 2028, is intended to provide continuity in financial reporting and operations during the audit and handoff.
• Compensation and incentives: The new CFO’s salary, bonus target, and $2.75M equity grant align his pay with company performance; investors may want to note the size and structure of equity awards as they can affect dilution and executive incentives.